查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807409

抗生素的全球市场:市场规模·占有率·趋势，产业分析 (各类药物·各类型·各作用机制·各地区)，2025年～2034年的市场预测

Antibiotics Market Size, Share, Trends, Industry Analysis Report By Drug Class, By Type, By Action Mechanism, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，抗生素市场规模将达到 758 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

抗生素是一种治疗药物，旨在抑製或消除有害细菌的生长，在医疗环境中控制细菌感染方面发挥核心作用。抗生素市场的发展受到人们对抗生素抗药性日益增长的担忧的影响，这重新激发了人们对开发下一代抗生素的兴趣。随着传统抗生素对不断进化的细菌菌株逐渐失去效力，製药公司和研究机构正在加强努力，探索新型化合物和创新治疗策略。这种转变，加上对标靶治疗和精准医疗的日益关注，正在重新定义市场格局。

人工智慧和机器学习平台在抗生素研发领域的日益融合也促进了市场成长。这些技术正在加速有前景的候选药物的识别，优化临床试验设计，并增强抗药性模式的预测模型。数位创新的应用减少了抗生素研发的时间和成本，提高了成功的可能性。因此，技术整合正成为重塑研究管道和拓展抗生素治疗未来前景的变革力量。

抗生素市场：分析概述

按类型划分，仿製抗生素将在2024年占销售额的81.48%，这得益于价格实惠、广泛供应以及领先品牌药专利到期等因素。

按作用机制划分，RNA合成抑制剂预计将在预测期内实现最快增长，因为它们能够精准靶向细菌途径并对抗抗药性细菌。

在严格的抗生素管理、监测系统和先进的治疗创新的支持下，北美将在2024年占全球抗生素市场的39.36%。

预计在预测期内，亚太市场将显着增长，这得益于人口增长、医疗基础设施改善以及人们对传染病认识的提高。

全球主要市场参与者包括安斯泰来製药、阿斯特捷利康、西普拉、费森尤斯卡比、葛兰素史克公司、希特罗医疗有限公司、鲁宾製药、默克公司、辉瑞和梯瓦製药工业公司。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球抗生素市场洞察

  • 市场概述
  • 抗生素的市场动态
    • 促进因素和机会
      • 人口老化成长
      • 研发进展
    • 限制与课题
      • 低获利能力所带来的经济和金融课题
      • 公众舆论与隐私先例
  • 大环境分析
  • 抗生素市场趋势
  • 价值链分析

第5章 抗生素市场:各类药物

  • 主要的分析结果
  • 简介
  • 头孢菌素类
  • 青霉素类
  • 氟喹诺酮类
  • 大环内酯类
  • 卡巴培南类
  • 氨基糖苷类
  • 磺胺类
  • 7-ACA
  • 其他

第6章 抗生素市场:各类型

  • 主要的分析结果
  • 简介
  • 品牌抗生素
  • 非专利抗生素

第7章 抗生素市场:各作用机制

  • 主要的分析结果
  • 简介
  • 细胞壁合成抑制剂
  • 蛋白质合成抑制剂
  • DNA合成抑制剂
  • RNA合成抑制剂
  • 分枝酸抑制剂

第8章 抗生素市场:各地区

  • 主要的分析结果
  • 简介
    • 抗生素市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各类药物·各地区(2020～2034年)
    • 北美:各类型·各地区(2020～2034年)
    • 北美:各作用机制·各地区(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类药物·各地区(2020～2034年)
    • 欧洲:各类型·各地区(2020～2034年)
    • 欧洲:各作用机制·各地区(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类药物·各地区(2020～2034年)
    • 亚太地区:各类型·各地区(2020～2034年)
    • 亚太地区:各作用机制·各地区(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类药物·各地区(2020～2034年)
    • 中东·非洲:各类型·各地区(2020～2034年)
    • 中东·非洲:各作用机制·各地区(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类药物·各地区，2020-2034年
    • 南美:各类型·各地区(2020～2034年)
    • 南美:各作用机制·各地区(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Astellas Pharma Inc.
  • AstraZeneca
  • Cipla
  • Fresenius Kabi AG
  • GSK plc
  • Hetero Healthcare Limited
  • Lupin Pharmaceuticals, Inc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: PM2083

The antibiotics market size is expected to reach USD 75.80 billion by 2034, according to a new study by Polaris Market Research. The report "Antibiotics Market Size, Share, Trends, Industry Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others), By Type, By Action Mechanism, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibiotics are therapeutic agents designed to inhibit the growth of or eliminate harmful bacteria, playing a central role in managing bacterial infections across healthcare environment. The antibiotics market is driven due to the escalating concern over antimicrobial resistance, which is prompting renewed interest in the development of next-generation antibiotics. Pharmaceutical companies and research institutions are intensifying their efforts to discover novel compounds and innovative treatment strategies as traditional antibiotics lose efficacy against evolving bacterial strains. This shift is redefining the market landscape, with a growing focus on targeted therapies and precision medicine.

The increasing integration of artificial intelligence and machine learning platforms in antibiotic discovery and development contributes to the market's growth. These technologies are accelerating the identification of promising drug candidates, optimizing clinical trial design, and enhancing predictive modeling for resistance patterns. The application of digital innovation reduces the time and cost associated with antibiotic development and increases the likelihood of successful outcomes. As a result, technological integration is emerging as a transformative force in reshaping the research pipeline and expanding the future scope of antibiotic therapies.

Antibiotics Market Report Highlights

In terms of type, the generic antibiotics segment held an 81.48% revenue share in 2024, fueled by affordability, broad availability, and patent expirations of major branded drugs.

Based on action mechanism, the RNA synthesis inhibitors segment is anticipated to register the fastest growth during the forecast period, driven by their precision in targeting bacterial pathways and addressing resistance.

North America captured 39.36% of the global antibiotics market in 2024, supported by stringent antibiotic stewardship, surveillance systems, and advanced treatment innovations.

The Asia Pacific market is poised for significant growth during the forecast period, propelled by population growth, improved healthcare infrastructure, and rising infectious disease awareness.

A few global key market players include Astellas Pharma Inc.; AstraZeneca; Cipla; Fresenius Kabi AG; GSK plc; Hetero Healthcare Limited; Lupin Pharmaceuticals, Inc; Merck & Co., Inc.; Pfizer Inc.; and Teva Pharmaceutical Industries Ltd..

Polaris Market Research has segmented the antibiotics market report on the basis of drug class, type, action mechanism, and region:

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

Cephalosporin

Penicillin

Fluoroquinolone

Macrolides

Carbapenems

Aminoglycosides

Sulfonamides

7-ACA

Others

By Type Outlook (Revenue, USD Billion, 2020-2034)

Branded Antibiotics

Generic Antibiotics

By Action Mechanism Outlook (Revenue, USD Billion, 2020-2034)

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Mycolic Acid Inhibitors

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Antibiotics Market Insights

  • 4.1. Antibiotics Market - Market Snapshot
  • 4.2. Antibiotics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Geriatric Population
      • 4.2.1.2. Advancements in Research and Development
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Economic and Financial Challenge due to Low Profitability
    • 4.2.3. Public opinion and privacy legal precedents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antibiotics Market Trends
  • 4.6. Value Chain Analysis

5. Antibiotics Market, By Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Antibiotics Market, By Drug Class, 2020-2034 (USD Billion)
  • 5.3. Cephalosporin
    • 5.3.1. Antibiotics Market, by Cephalosporin,2020-2034 (USD Billion)
  • 5.4. Penicillin
    • 5.4.1. Antibiotics Market, by Penicillin,2020-2034 (USD Billion)
  • 5.5. Fluoroquinolone
    • 5.5.1. Antibiotics Market, by Fluoroquinolone,2020-2034 (USD Billion)
  • 5.6. Macrolides
    • 5.6.1. Antibiotics Market, by Macrolides,2020-2034 (USD Billion)
  • 5.7. Carbapenems
    • 5.7.1. Antibiotics Market, by Carbapenems,2020-2034 (USD Billion)
  • 5.8. Aminoglycosides
    • 5.8.1. Antibiotics Market, by Aminoglycosides,2020-2034 (USD Billion)
  • 5.9. Sulfonamides
    • 5.9.1. Antibiotics Market, by Sulfonamides,2020-2034 (USD Billion)
  • 5.10. 7-ACA
    • 5.10.1. Antibiotics Market, by 7-ACA,2020-2034 (USD Billion)
  • 5.11. Others
    • 5.11.1. Antibiotics Market, by Others,2020-2034 (USD Billion)

6. Antibiotics Market, By Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Antibiotics Market, By Type, 2020-2034 (USD Billion)
  • 6.3. Branded Antibiotics
    • 6.3.1. Antibiotics Market, by Branded Antibiotics,2020-2034 (USD Billion)
  • 6.4. Generic Antibiotics
    • 6.4.1. Antibiotics Market, by Generic Antibiotics,2020-2034 (USD Billion)

7. Antibiotics Market, By Action Mechanism

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Antibiotics Market, By Action Mechanism, 2020-2034 (USD Billion)
  • 7.3. Cell Wall Synthesis Inhibitors
    • 7.3.1. Antibiotics Market, by Cell Wall Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.4. Protein Synthesis Inhibitors
    • 7.4.1. Antibiotics Market, by Protein Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.5. DNA Synthesis Inhibitors
    • 7.5.1. Antibiotics Market, by DNA Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.6. RNA Synthesis Inhibitors
    • 7.6.1. Antibiotics Market, by RNA Synthesis Inhibitors,2020-2034 (USD Billion)
  • 7.7. Mycolic Acid Inhibitors
    • 7.7.1. Antibiotics Market, by Mycolic Acid Inhibitors,2020-2034 (USD Billion)

8. Antibiotics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Antibiotics Market Assessment, By Geography, by Region, 2020-2034 (USD Billion)
  • 8.3. Antibiotics Market - North America
    • 8.3.1. North America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.3.2. North America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.3.3. North America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.3.4. Antibiotics Market - US
      • 8.3.4.1. US: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.3.5. Antibiotics Market - Canada
      • 8.3.5.1. Canada: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.4. Antibiotics Market - Europe
    • 8.4.1. Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.4. Antibiotics Market - UK
      • 8.4.4.1. UK: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.5. Antibiotics Market - France
      • 8.4.5.1. France: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.6. Antibiotics Market - Germany
      • 8.4.6.1. Germany: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.7. Antibiotics Market - Italy
      • 8.4.7.1. Italy: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.8. Antibiotics Market - Spain
      • 8.4.8.1. Spain: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.9. Antibiotics Market - Netherlands
      • 8.4.9.1. Netherlands: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.10. Antibiotics Market - Russia
      • 8.4.10.1. Russia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.4.11. Antibiotics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.5. Antibiotics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.4. Antibiotics Market - China
      • 8.5.4.1. China: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.5. Antibiotics Market - India
      • 8.5.5.1. India: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.6. Antibiotics Market - Malaysia
      • 8.5.6.1. Malaysia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.7. Antibiotics Market - Japan
      • 8.5.7.1. Japan: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.8. Antibiotics Market - Indonesia
      • 8.5.8.1. Indonesia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.9. Antibiotics Market - South Korea
      • 8.5.9.1. South Korea: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.10. Antibiotics Market - Australia
      • 8.5.10.1. Australia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.5.11. Antibiotics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.6. Antibiotics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.4. Antibiotics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.5. Antibiotics Market - UAE
      • 8.6.5.1. UAE: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.6. Antibiotics Market - Israel
      • 8.6.6.1. Israel: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.7. Antibiotics Market - South Africa
      • 8.6.7.1. South Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.6.8. Antibiotics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • 8.7. Antibiotics Market - Latin America
    • 8.7.1. Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.4. Antibiotics Market - Mexico
      • 8.7.4.1. Mexico: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.5. Antibiotics Market - Brazil
      • 8.7.5.1. Brazil: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.6. Antibiotics Market - Argentina
      • 8.7.6.1. Argentina: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
    • 8.7.7. Antibiotics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Astellas Pharma Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fresenius Kabi AG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. GSK plc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hetero Healthcare Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lupin Pharmaceuticals, Inc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck & Co., Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Pfizer Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teva Pharmaceutical Industries Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 2 Global Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 3 Global Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 4 North America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 5 North America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 6 North America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 7 US: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 8 US: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 9 US: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 10 Canada: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 11 Canada: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 12 Canada: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 13 Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 14 Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 15 Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 16 UK: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 17 UK: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 18 UK: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 19 France: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 20 France: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 21 France: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 22 Germany: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 23 Germany: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 24 Germany: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 25 Italy: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 26 Italy: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 27 Italy: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 28 Spain: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 29 Spain: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 30 Spain: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 34 Russia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 35 Russia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 36 Russia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 43 China: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 44 China: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 45 China: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 46 India: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 47 India: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 48 India: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 52 Japan: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 53 Japan: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 54 Japan: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 58 South Korea: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 59 South Korea: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 60 South Korea: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 61 Australia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 62 Australia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 63 Australia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 73 UAE: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 74 UAE: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 75 UAE: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 76 Israel: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 77 Israel: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 78 Israel: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 79 South Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 80 South Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 81 South Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 85 Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 86 Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 87 Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 88 Mexico: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 89 Mexico: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 90 Mexico: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 91 Brazil: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 92 Brazil: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 93 Brazil: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 94 Argentina: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 95 Argentina: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 96 Argentina: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Antibiotics Market, by Drug Class, by Region, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Antibiotics Market, by Type, by Region, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Antibiotics Market, by Action Mechanism, by Region, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Antibiotics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market By Drug Class
  • Figure 7. Antibiotics Market, By Drug Class, 2024 & 2034 (USD Billion)
  • Figure 8. Market By Type
  • Figure 9. Antibiotics Market, By Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market By Action Mechanism
  • Figure 11. Antibiotics Market, By Action Mechanism, 2024 & 2034 (USD Billion)